We are live on
!
Find out more
PM
Prosight Management Portfolio holdings
AUM
$610M
1-Year Est. Return
40.86%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+40.86%
3 Year Est. Return
+46.17%
5 Year Est. Return
+1.2%
10 Year Est. Return
–
AUM
$394M
AUM Growth
+$59.8M
(+18%)
Cap. Flow
+$62M
Cap. Flow
% of AUM
15.71%
Top 10 Holdings %
Top 10 Hldgs %
57.09%
Holding
61
New
12
Increased
17
Reduced
12
Closed
17
Top Buys
| 1 |
McKesson
MCK
|
+$19.9M |
| 2 |
AbCellera Biologics
ABCL
|
+$18.6M |
| 3 |
DexCom
DXCM
|
+$9.09M |
| 4 |
Janux Therapeutics
JANX
|
+$8.92M |
| 5 |
BridgeBio Pharma
BBIO
|
+$7.53M |
Top Sells
| 1 |
Kelly Services Class A
KELYA
|
+$10.5M |
| 2 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$8.74M |
| 3 |
Alkermes
ALKS
|
+$6.63M |
| 4 |
OrthoPediatrics
KIDS
|
+$5.76M |
| 5 |
Option Care Health
OPCH
|
+$5.68M |
Sector Composition
| 1 | Healthcare | 97.26% |
| 2 | Industrials | 2.74% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cogent Biosciences
COGT
$6.72B
| $4.44M | 1.13% |
410,830
-89,170
| -18% | -$868K |
|
|
FLNA
27
PUT
Filana Therapeutics
FLNA
$53.1M
| $4.38M | 1.11% |
+148,900
| New | +$3.43M |
|
|
BPMC
28
DELISTED
Blueprint Medicines
BPMC
| $4.36M | 1.1% |
+47,100
| New | +$4.68M |
|
|
TECX
29
Tectonic Therapeutic
TECX
$613M
| $4.17M | 1.06% |
137,614
+70,153
| +104% | +$1.28M |
|
30
CytomX Therapeutics
CTMX
$801M
| $3.57M | 0.9% |
+3,022,109
| New | +$3.84M |
|
31
Sight Sciences
SGHT
$286M
| $3.35M | 0.85% |
+531,222
| New | +$3.57M |
|
32
Viking Therapeutics
VKTX
$4.39B
| $3.04M | 0.77% |
48,000
-67,000
| -58% | -$3.93M |
|
33
Rocket Pharmaceuticals
RCKT
$399M
| $2.94M | 0.75% |
+159,369
| New | +$3.26M |
|
34
Corbus Pharmaceuticals
CRBP
$167M
| $2.68M | 0.68% |
+130,000
| New | +$6.65M |
|
|
MURA
35
DELISTED
Mural Oncology
MURA
| $1.79M | 0.45% |
570,620
+95,162
| +20% | +$310K |
|
36
Maravai LifeSciences
MRVI
$1.04B
| $1.73M | 0.44% |
+208,200
| New | +$1.8M |
|
|
VINC
37
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $1.58M | 0.4% |
110,325
-14,096
| -11% | -$193K |
|
|
RNTX
38
Rein Therapeutics
RNTX
$80.9M
| $1.32M | 0.33% |
372,157
+107,157
| +40% | +$286K |
|
39
PUT
CorVel
CRVL
$3.16B
| $915K | 0.23% |
+8,400
| New | +$840K |
|
|
SEM
40
DELISTED
Select Medical
SEM
| $909K | 0.23% |
+48,377
| New | +$927K |
|
41
Ovid Therapeutics
OVID
$465M
| $860K | 0.22% |
729,208
-345,792
| -32% | -$361K |
|
42
Immunome
IMNM
$2.6B
| $572K | 0.15% |
39,135
-25,865
| -40% | -$368K |
|
43
Immuneering
IMRX
$334M
| $473K | 0.12% |
190,000
-360,000
| -65% | -$524K |
|
44
Acadia Healthcare
ACHC
$2.97B
| $359K | 0.09% |
+5,666
| New | +$409K |
|
45
CALL
Shattuck Labs
STTK
$647M
| $303K | 0.08% |
+86,800
| New | +$324K |
|
46
Addus HomeCare
ADUS
$2.06B
| – | – |
-12,500
| Closed | -$1.45M |
|
|
47
Alkermes
ALKS
$8.66B
| – | – |
-275,000
| Closed | -$6.63M |
|
48
BioCryst Pharmaceuticals
BCRX
$2.39B
| – | – |
-398,700
| Closed | -$2.46M |
|
49
Biomea Fusion
BMEA
$93.3M
| – | – |
-124,377
| Closed | -$560K |
|
50
CVS Health
CVS
$135B
| – | – |
-40,000
| Closed | -$2.36M |
|
Similar funds
PL
BFC
ACM
FFWA
SAM
CBB
AIG
IA